v3 Template
E

EVerZom

Biotechnology ~540 employees
Founded
--
Employees (Est.)
~540
27 leaders known
Total Funding
$11.0M
Funding Rounds
1
Last Funding
2025-10-14

About EVerZom

EVerZom is a biotech company specializing in exosome-based therapies, aiming to revolutionize the therapeutic landscape of gene and cell therapies. Founded in 2019, their mission is to unlock the exosome revolution by developing innovative treatments for tissue healing and organ regeneration, targeting diseases with high unmet medical needs. They focus on becoming a leading biotech in this field with a proprietary innovation platform and therapeutic programs.

Products & Services

Innovation Platform:A patented platform covering cell sourcing, exosome generation, loading, and formulation, used to develop proprietary products in regenerative medicine and co-development partnerships.
Therapeutic Programs:Two drug candidates in development: one for healing digestive tissues (primary indication: Crohn's fistula) and another for organ regeneration (liver and kidney), showing significant preclinical results in healing, inflammation reduction, and fibrosis.
EViv:A therapeutic program focused on specific regenerative applications (details under therapeutic programs).

Specialties

Exosome-based therapies Regenerative medicine Tissue healing Organ regeneration Extracellular vesicles (EVs) Biomanufacturing technology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Round
T: -
FT: Venture Round
A: 11000000
MR: -
FA: €10M
FAN: 11000000
D: 2025-10-14
FD: 2025-10-14
6 investors
Venture Round Latest
2025-10-14
$11.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michel Finance

Board President

LinkedIn (Pro only)
J

Jean-François Brepson

Board member

J

Julie Rachline

Board member

LinkedIn (Pro only)
L

Laurent Bracco

Life Sciences - Biotechnology Consultant & Business angel

T

Thibaut de Tessières

CEO Tessalu

A

Amanda Brun

Co founder - Board President

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

EVerZom Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~540 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro